SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012368
Filing Date
2019-08-14
Accepted
2019-08-14 12:14:46
Documents
56
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 419370
2 ex3.htm EX-3 20714
3 ex31-1.htm EX-31.1 12698
4 ex31-2.htm EX-31.2 12955
5 ex32-1.htm EX-32.1 13038
  Complete submission text file 0001493152-19-012368.txt   2330409

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pcsa-20190630.xml EX-101.INS 273508
7 XBRL SCHEMA FILE pcsa-20190630.xsd EX-101.SCH 39864
8 XBRL CALCULATION FILE pcsa-20190630_cal.xml EX-101.CAL 49265
9 XBRL DEFINITION FILE pcsa-20190630_def.xml EX-101.DEF 84418
10 XBRL LABEL FILE pcsa-20190630_lab.xml EX-101.LAB 242235
11 XBRL PRESENTATION FILE pcsa-20190630_pre.xml EX-101.PRE 173670
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184948 | Film No.: 191024510
SIC: 2834 Pharmaceutical Preparations